Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation

被引:0
|
作者
Xiaodong Wang
Uet Yu
Chunlan Yang
Chunjing Wang
Xiaoling Zhang
Yue Li
Changgang Li
Feiqiu Wen
Sixi Liu
机构
[1] Shenzhen Children’s Hospital,Department of Hematology and Oncology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:271 / 275
页数:4
相关论文
共 50 条
  • [1] Cytomegalovirus (CMV)-specific cytotoxic T lymphocyte therapy resolve CMV diseases and refractory CMV infections in paediatric recipients of allogeneic haematopoietic stem cell transplantation
    Wang, Xiaodong
    Yu, Uet
    Yang, Chunlan
    Wang, Chunjing
    Zhang, Xiaoling
    Li, Yue
    Li, Changgang
    Wen, Feiqiu
    Liu, Sixi
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (02) : 271 - 275
  • [2] Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation
    G Avetisyan
    K Larsson
    J Aschan
    C Nilsson
    M Hassan
    P Ljungman
    [J]. Bone Marrow Transplantation, 2006, 38 : 687 - 692
  • [3] Impact on the cytomegalovirus (CMV) viral load by CMV-specific T-cell immunity in recipients of allogeneic stem cell transplantation
    Avetisyan, G.
    Larsson, K.
    Aschan, J.
    Nilsson, C.
    Hassan, M.
    Ljungman, P.
    [J]. BONE MARROW TRANSPLANTATION, 2006, 38 (10) : 687 - 692
  • [4] Adoptive Immunotherapy with CMV Specific Cytotoxic T Lymphocytesfor Stem Cell Transplant Patients with Refractory CMV Infections
    Bao, Lei
    Cowan, Morton Jerome
    Dunham, Kimberly
    Horn, Biljana N.
    McGuirk, Joseph
    Gilman, Andrew
    Lucas, Kenneth
    [J]. BLOOD, 2011, 118 (21) : 1723 - 1723
  • [5] Adoptive Transfusion of Cytomegalovirus-Specific Cytotoxic T Lymphocytes (CMV-CTLS) for Pediatric Patients with CMV Diseases after Allogeneic Hematopoietic Stem Cell Transplantation
    Yu, U.
    Wang, X.
    Yang, C.
    Wang, C.
    Zhang, X.
    Li, Y.
    Zhou, X.
    Liu, S.
    [J]. PEDIATRIC BLOOD & CANCER, 2021, 68 : S210 - S210
  • [6] Adoptive Immunotherapy With CMV-specific Cytotoxic T Lymphocytes for Stem Cell Transplant Patients With Refractory CMV Infections
    Bao, Lei
    Cowan, Morton J.
    Dunham, Kimberly
    Horn, Biljana
    McGuirk, Joseph
    Gilman, Andrew
    Lucas, Kenneth G.
    [J]. JOURNAL OF IMMUNOTHERAPY, 2012, 35 (03) : 293 - 298
  • [7] Efficacy of cytomegalovirus specific immunoglobulins (cmv-ig) in reducing cmv reactivation in paediatric haematopoietic stem cell transplant
    Geurten, C.
    Ghinai, R.
    Munford, H.
    Cole, N.
    Norton, A.
    Lawson, S.
    [J]. BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 292 - 293
  • [8] Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality
    Liu, J.
    Kong, J.
    Chang, Y. J.
    Chen, H.
    Chen, Y. H.
    Han, W.
    Wang, Y.
    Yan, C. H.
    Wang, J. Z.
    Wang, F. R.
    Chen, Y.
    Zhang, X. H.
    Xu, L. P.
    Liu, K. Y.
    Huang, X. J.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (12) : 1121.e9 - 1121.e15
  • [9] Risk Factors for Recurrent CMV Reactivation in CMV Seropositive Recipients Following T Cell Depleted Haematopoietic Stem Cell Transplantation
    Ibrahim, Abeer
    Ingram, Wendy
    Price, Nicola
    Davies, David
    Wilson, Keith
    [J]. BLOOD, 2014, 124 (21)
  • [10] Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status
    Servais, S.
    Dumontier, N.
    Biard, L.
    Schnepf, N.
    Resche-Rigon, M.
    de Latour, R. Peffault
    Scieux, C.
    Robin, M.
    Meunier, M.
    Xhaard, A.
    de Fontbrune, F. Sicre
    Le Goff, J.
    Socie, G.
    Simon, F.
    Mazeron, M. -C.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2016, 22 (03) : 289.e1 - 289.e7